mechanisms of alk resistance & implications for treatment
Published 9 years ago • 228 plays • Length 22:46
Download video MP4
Download video MP3
Similar videos
-
3:44
alk inhibitors for acquired resistance: zykadia and alectinib
-
31:43
new ideas and new treatment options for acquired resistance for alk/ros1
-
1:47
alk rearrangements: what are they, and who has them?
-
2:20
timing of second generation alk inhibitors: first line vs. treatment after acquired resistance
-
2:52
understanding acquired resistance in alk lung cancer
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
26:54
what is acquired resistance to targeted therapy, and why does it occur?
-
29:51
current & emerging approaches to acquired resistance for alk/ros1
-
0:56
crizotinib for first line treatment of alk or ros1 rearrangements
-
2:00
ceritinib and other second generation alk inhibitors for acquired resistance in alk-positive nsclc
-
6:20
oncogene-driven metastatic nsclc: frontline treatment & resistance mechanisms - onctalk 2022
-
10:45
case based panel discussion 2.3 developing resistance to alk inhibitors, areas of progression after
-
9:59
case based panel discussions - alk positive, developing resistance to alk inhibitors and next steps
-
4:58
how do the new alk inhibitor drugs compare to xalkori (crizotinib) for alk lung cancer patients?
-
17:30
gracecast-084_lung-cancer_alk inhibition: science and early clinical experience by dr. ben solomon
-
2:15
new alk inhibitor drugs vs xalkori (crizotinib) for alk lung cancer patients
-
1:07:25
ros1 alk initial treatment, acquired resistance with melina marmarelis, md and charu aggarwal, md
-
48:16
alk/ros1: initial treatment, acquired resistance, q&a charu aggarwal, md and melina marmarelis, md
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
Clip.africa.com - Privacy-policy